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Abstract
We present a new modelling approach for longitudinal count data that is mo-
tivated by the increasing availability of longitudinal RNA-sequencing experi-
ments. The distribution of RNA-seq counts typically exhibits overdispersion,
zero-inflation and heavy tails; moreover, in longitudinal designs repeated mea-
surements from the same subject are typically (positively) correlated. We pro-
pose a generalized linear mixed model based on the Poisson-Tweedie distribu-
tion that can flexibly handle each of the aforementioned features of longitudinal
overdispersed counts. We develop a computational approach to accurately eval-
uate the likelihood of the proposed model and to perform maximum likelihood
estimation. Our approach is implemented in the R package ptmixed, which can
be freely downloaded from CRAN. We assess the performance of ptmixed on
simulated data and we present an application to a dataset with longitudinal
RNA-sequencing measurements from healthy and dystrophic mice. The applica-
bility of the Poisson-Tweedie mixed-effects model is not restricted to longitudinal
RNA-seq data, but it extends to any scenario where non-independent measure-
ments of a discrete overdispersed response variable are available.
Keywords: generalized linear mixed model; heavy tails; high-throughput se-
quencing; longitudinal count data; overdispersion; zero-inflation.
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1 Introduction
In the last decade, RNA-sequencing (RNA-seq, Mortazavi et al. 2008) has progressively
replaced microarrays and has become the standard method to measure gene expression.
A typical goal of RNA-seq studies is the identification of genes that are differentially
expressed across groups of subjects, or are associated with a variable of interest. To
this end, a statistical model is postulated to relate the expression levels of a gene to the
variable(s) of interests and relevant confounders, and hypothesis testing is performed
to assess the significance of the relevant differences or associations. While microarrays
yielded continuous measurements that could be analysed using models that relied on
normality assumptions (Smyth, 2004), RNA-seq measurents are discrete and require
statistical models more suitable for the analysis of count data. While the very first
attempts to model RNA-seq data relied on the use of the Poisson distribution (Marioni
et al., 2008), it was soon observed that the distribution of RNA-seq counts is typically
characterized by phenomena such as overdispersion (the variation of counts is higher
than the mean), zero-inflation and heavy tails, that the Poisson distribution cannot
account for.
To take overdispersion into account, Robinson et al. (2010) and Love et al. (2014)
proposed two statistical models based on the negative binomial (NB) distribution, im-
plemented in the R packages edgeR and DESeq2. To deal with small sample sizes,
which were a very common feature of the first cross-sectional RNA-seq studies, they
proposed to estimate the dispersion parameter of the NB distribution by borrowing
information across genes. Esnaola et al. (2013) tested the adequacy of the NB distri-
bution on data from a large-scale RNA-seq experiment. They showed that although
the NB fitted sufficiently well the empirical distribution of counts for many genes, such
distribution was inadequate for a relevant proportion of genes that exhibit strong zero-
inflation or heavy tails. Therefore, they proposed a more flexible generalized linear
model (GLM) based on the Poisson-Tweedie (PT) distribution, implemented in the R
packages tweeDEseq. The PT is a three-parameter distribution that encompasses the
NB as special case, and differently from the NB it can accommodate different levels
of zero-inflation and heavy-tailness for a given amount of overdispersion. A differ-
ent approach, called limma-voom, was proposed by Law et al. (2014), who combined
a linear model for the log-transformed counts with sample-specific precision weights,
making it possible to apply to RNA-seq measurements a pipeline originally developed
for microarray data.
At the beginning of the diffusion of RNA-seq, the high sequencing costs discouraged
the setup of longitudinal RNA-seq studies; for this reason, limma-voom, edgeR, DE-
Seq2 and tweeDEseq were developed to deal with cross-sectional RNA-seq datasets.
However, interest in the dynamic evolution of gene expression and declining sequenc-
ing costs are nowadays motivating more longitudinal studies. One such example is a
mice experiment carried out at the Leiden University Medical Center (LUMC) that
aimed to identify biomarkers of disease progression for Duchenne Muscular Dystrophy
(DMD). In this experiment, described more in detail in Section 4, blood samples were
2
collected from healthy and dystrophic mice every 6 weeks over a period of 30 weeks,
and gene expression in blood was quantified using RNA-seq.
In longitudinal studies, repeated measurements are collected from the same subject at
several time points. This introduces correlation between the repeated measurements
from the same subject, a correlation that is not present in cross-sectional designs where
all samples can be assumed to be independent. Nevertheless, often longitudinal RNA-
seq data are analysed using popular approaches (mostly edgeR, DESeq2 and limma-
voom) for cross-sectional RNA-seq data, either ignoring the longitudinal nature of the
data and assuming samples from the same individual to be independent, or adding
for each individual a subject-specific indicator as a covariate (fixed effect). Cui et al.
(2016) showed that modelling longitudinal RNA-seq data using such approaches re-
sults into increased false positive rates (FPR), or in a loss of power when the FPR is
controlled. They argued that longitudinal RNA-seq data should instead be analyzed
using generalized linear mixed models (GLMMs, McCulloch et al., 2008) and they
illustrated their point by comparing those “improper” modelling approaches to a Pois-
son GLMM. They motivated their choice to use the Poisson distribution instead of a
more flexible alternative based on frequent convergence problems that they encountered
when attempting to fit a negative binomial GLMM with random intercept. Although
their choice of a Poisson GLMM simplifies model estimation, it is clear that such a
model cannot account for the different combinations of overdispersion, zero-inflation
and heavy tails typical of RNA-seq counts. Therefore, the use of GLMMs based on
more flexible distributions for count data, such as the NB and PT distributions, should
be preferred even if their estimation is more involved.
Recent proposals tailored to the analysis of longitudinal RNA-seq data include MaSig-
Pro (Nueda et al., 2014), ShrinkBayes (van de Wiel et al., 2014), DyNB (A¨ijo¨ et al.,
2014) and timeSeq (Sun et al., 2016). MaSigPro fits a NB GLM that lets the expected
value of a gene depend on time polynomials and their interaction with a group indicator;
similarly to the methods for cross-sectional RNA-seq, this approach relies on a simple
GLM that does not model properly the repeated measurements design. ShrinkBayes
can fit Poisson, NB, zero-inflated Poisson (ZIP) and zero-inflated NB (ZINB) GLMMs
that can accommodate a random intercept. Owing to the possibility to choose the ZIP
and the ZINB as distributions, this approach can be employed to model both zero-
inflation and the correlation between repeated measurements. However, ShrinkBayes
does not allow to fit GLMMs for heavy-tailed distributions. Moreover, the method
requires the user to preselect one specific distributional shape that is fitted to all
genes, rather than letting the estimation procedure determine it automatically and
separately for each gene as in the case of the PT family of models proposed by Esnaola
et al. (2013). Finally, often interest may lie in assessing the joint significance of two or
more coefficients, for example that of a main effect and of the corresponding interaction
term, or in testing a system of linear combinations of the regression coefficients (an
example of this type of hypotheses can be found in Section 4). However, the R package
ShrinkBayes allows users to test only hypotheses that involve a single regression co-
efficient (although with some additional programming one may still be able test more
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complex hypotheses). DyNB fits a semiparametric model that combines a NB GLM
with Gaussian-processes regression. Finally, timeSeq considers a NB GLMM where
time is modelled using splines. Both DyNB and timeSeq are semiparametric and re-
stricted to the NB case, thus they do not attempt to model zero-inflation and heavy
tails.
In this paper we present ptmixed, a Poisson-Tweedie GLMM that is suitable for the
analysis of longitudinal RNA-seq data and that, more in general, can be employed to
flexibly model longitudinal counts that are overdispersed, zero-inflated and/or heavy
tailed. Owing to the use of the PT distribution, our approach is capable to capture
different combinations of zero-inflation and heavy-tails that typically characterize the
distribution of overdispersed counts, and it automatically performs model selection
among a range of different discrete distributions separately for each gene, similarly
to tweeDEseq (Esnaola et al., 2013). Moreover, our mixed-effects approach allows
to properly model within-subject correlations (Cui et al., 2016) and to flexibly test
both one-dimensional and multi-dimensional statistical hypotheses. To the best of
our knowledge, our proposal is the first extension of the PT GLM of Esnaola et al.
(2013) to the context of random effects models, while a different extension based on
generalized estimating equations has been proposed by Bonat et al. (2018). We provide
an R implementation of functions for the estimation the proposed model and related
hypothesis testing through the R package ptmixed (Signorelli et al., 2020), which can
be freely downloaded from the Comprehensive R Archive Network (CRAN).
The remainder of the article is organized as follows: in Section 2 we introduce our
model, describe the use of the adaptive Gauss Hermite quadrature rule to approximate
its likelihood, present our computational approach to maximum likelihood estimation
and discuss the use of Wald and likelihood ratio tests for hypothesis testing. In Section
3 we assess the performance of our method using simulated data, and we compare it
to several alternative methods that are commonly used in the analysis of longitudinal
RNA-seq studies. In Section 4 we illustrate an application of ptmixed to the data from
our motivating experiment. We conclude by discussing advantages and limitations of
our approach in Section 5.
2 Methods
2.1 Filtering and normalization of RNA-seq data
The analysis of RNA-seq counts requires careful consideration of two pre-processing
steps: filtering and normalization. First, because the expression profiles of lowly ex-
pressed genes are typically very noisy and strongly subject to measurement error,
those genes are usually filtered out and excluded from the statistical analysis (Sha
et al., 2015). Filtering allows to focus on those genes for which sufficient information
is available and to mitigate the severity of multiple testing corrections. Furthermore,
gene expression profiles are normalized to remove the effect of systematic technical
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biases due to the specific technology used to measure gene expression. Hereafter we as-
sume that lowly-expressed genes have been preliminarly filtered out, and that a vector
of sample-specific normalization weights has been obtained using one of the available
RNA-seq normalization methods, such as for example the Trimmed Mean of M values
(TMM) method of Robinson and Oshlack (2010).
2.2 Poisson-Tweedie generalized linear mixed model
We consider a longitudinal design in which j = 1, ...,mi repeated measurements on
g = 1, ...,G genes are available for i = 1, ..., n individuals or subjects. The Poisson-
Tweedie mixed-effects model assumes that conditionally on a vector of subject-specific
random effects vg = (vg1, ..., vgn), the expression value of gene g measured in the j-th
sample from individual i, Ygij, follows a PT distribution with mean µgij, dispersion Dg
and power ag:
Ygij ∣ vgi ∼ PT(µgij, Dg, ag)
log (µgij) = xTijβg + zTijvgi + oij
vgi
i.i.d.∼ N(0,Σg), (1)
where the mean expression profile µgij depends on a vector of fixed effects xij, a vector
of random effects zij and on an offset term oij that corresponds to the logarithm of
the sample-specific normalization weights discussed in Section 2.1. xij will typically
comprise both covariates of interests and relevant confounders. Although in principle
it is possible to consider any random effect structure for zij, hereafter we focus on the
case in which zij = 1 in (1), so that vgi i.i.d.∼ N(0, σ2g) denotes a subject-specific random
intercept.
The PT distribution (El-Shaarawi et al., 2011), also known as generalized NB distri-
bution (Gerber, 1991), is a very flexible three-parameter distribution for discrete data
that can be characterized in terms of a mean µ > 0, dispersion D ≥ 1 and power a ≤ 1.
It encompasses several discrete random variables as special cases, including the Poisson
(a = 1,D = 1), Poisson inverse Gaussian (a = 0.5), NB (a = 0), Po´lia-Aepply (a = −1)
and Neyman type A (a → −∞) distributions. El-Shaarawi et al. (2011) pointed out
that the PT is particularly useful to account for extra zero-inflation or heavy tails
compared to the NB distribution. In Figure 1 of Supplementary File 1 we provide
a graphical illustration of the flexibility of the PT, comparing the probability mass
function (pmf) of the PT distribution for different values of D and a. When D is close
to the boundary value 1, the PT pmf is very similar to that of a Poisson distribution
irrespective of the value of a. For larger values of D, the difference between pmfs
becomes more noticeable: zero-inflation arises with negative values of a, while heavy
tails are obtained when a is positive.
Esnaola et al. (2013) proposed to exploit the flexibility of the PT in the analysis of
cross-sectional RNA-seq data and introduced the PT generalized linear model (GLM),
highlighting how the PT power parameter allows to perform automatic model selection
from a wide range of different discrete distributions. They showed that for several genes
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the distribution of RNA-seq counts cannot be assumed to be NB, and that in those
cases the use of the PT distribution allows to achieve a better model fit, to improve
the estimation of the dispersion parameter and to control the type I error of tests on
differences in mean between two groups already with moderate sample sizes. In this
article we extend the model of Esnaola et al. (2013) by introducing the Poisson-Tweedie
GLMM of equation (1), thus extending the applicability of the PT class of models to
the analysis of longitudinal data.
2.3 Maximum likelihood estimation
Maximum likelihood (ML) estimation of mixed models is usually carried out by maxi-
mizing the marginal likelihood
L(θ) = n∏
i=1
mi∏
j=1 f(ygij; θ) = n∏i=1 mi∏j=1∫ ∞−∞ f(ygij ∣vgi; θ)f(vgi; θ)dvgi,
whose computation requires the integration of the joint likelihood of the response yg and
the random effects vg over the distribution of the random effects. While for the linear
mixed model it is possible to perform this integration analytically, for more complex
GLMMs computation of the marginal likelihood requires a numeric approximation of
the integrals over the random effects (we will discuss this in Section 2.3.1).
The marginal likelihood of the PT mixed model with random intercept can be written
as
L(βg,Dg, ag, σ2g ∣yg,X) = n∏
i=1 ∫ ∞−∞ 1√2piσ2g e−
v2gi
2σ2g
mi∏
j=1∫ ∞0 zygije−zygij! f(z)dz dvgi, (2)
where f(z) = f(z∣βg,Dg, ag) denotes the density of the Tweedie distribution. If a more
complex random effects structure is specified, then the unidimensional integrals in dvgi
in (2) have to be replaced with multidimensional ones.
A major complication with the computation of (2) is that because the pmf of the PT
distribution does not have a closed-form expression, the computation of the marginal
likelihood requires numeric evaluation for both of the integrals in (2). As a consequence,
ML estimation requires the implementation of a combination of numerical integration
and optimization techniques that we illustrate in Sections 2.3.1 and 2.3.2.
2.3.1 Evaluation of the likelihood function
To compute the marginal likelihood in (2) we first need to evaluate numerically the pmf∫ ∞0 zygij e−zygij ! f(z)dz of the PT distribution, and then to carry out a numeric approxima-
tion of the integrals with respect to the random effects. We base the numeric evaluation
of the PT pmf on the recursive formula proposed by El-Shaarawi et al. (2011), resort-
ing in particular to its implementation in the R package tweeDEseq (Esnaola et al.,
2013). Then, we implement the adaptive Gauss-Hermite quadrature (AGHQ) method
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(Pinheiro and Chao, 2006) to approximate the improper integrals associated to the
random effects.
To illustrate how the AGHQ method works, we begin by explaining the simpler Gauss-
Hermite quadrature (GHQ) method. Let
h(vgi) = 1√
2piσ2g
e
− v2gi
2σ2g
mi∏
j=1∫ ∞0 zygije−zygij! f(z)dz,
so that (2) can be rewritten as ∏ni=1 ∫ ∞−∞ h(vgi)dvgi. To approximate each integral∫ ∞−∞ h(vgi)dvgi with the GHQ method one first needs to rewrite the integrand h(vgi) as
the product between the kernel w(vgi) = e−v2gi and a function q(vgi) = h(vgi)ev2gi . Then,
the integral of q(vgi) with respect to the kernel w(vgi) is approximated with a weighted
average of the function q evaluated at k predetermined abscissae v1gi, v
2
gi, ..., v
k
gi:
∫ ∞−∞ h(vgi)dvgi = ∫ ∞−∞ w(vgi)q(vgi)dvgi ≈ k∑r=1wrq(vrgi), (3)
where (w1, ...,wk) is a vector of known weights (Steen et al., 1969). The quality of the
approximation in (3), however, depends on whether the mass of q(x) is concentrated
around 0; for this reason, in the AGHQ method the numerical integration is instead
performed through an adaptive algorithm whereby one first obtains estimates of the
mode vˆ of q(vgi) and of sˆ2 = −[d2 log q(vˆ)/dv2gi]−1, and then performs the change of
variable ugi = vgi−vˆsˆ√2 , such that
∫ ∞−∞ h(vgi)dvgi ≈ sˆ√2 k∑r=1wrq(vˆ + sˆ√2urgi). (4)
When k = 1, the AGHQ is equivalent to the Laplace approximation (LA), which is often
employed to approximate the likelihood of GLMMs. Our choice to employ the AGHQ
method is motivated by the fact that approximating the likelihood of GLMMs with the
simpler but less accurate LA can result in frequent convergence problems during ML
estimation. This problem is particularly frequent for mixed-effects extensions of the
Poisson GLMM, such as for example the NB GLMM, and it is commonly encountered
when analysing longitudinal RNA-seq counts. For example, Cui et al. (2016) attempted
to fit NB GLMMs to a dataset with longitudinal RNA-seq measurements by employ-
ing glmmADMB (Fournier et al., 2012), an R package where the likelihood of GLMMs is
approximated using the LA, and reported frequent convergence problems that induced
them to fit the simpler Poisson GLMM instead of the NB GLMM. However, such con-
vergence problems can often be solved if the likelihood function is approximated using
an AGHQ with a suitable number of quadrature points instead of the LA. Moreover,
ML estimates of the variance components obtained with the LA have been shown to
suffer from severe bias, which vanishes if an AGHQ approximation with a sufficient
number of quadrature points is used (Pinheiro and Chao, 2006). Overall, although it is
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a bit more computationally intensive than the LA, the AGHQ produces more precise
evaluations of the likelihood, reduces convergence issues, yields more accurate param-
eter estimates and allows a better type I error control. In Section 3.2 we will provide
a demonstration of the gain associated to the use of the AGHQ in place of the LA.
2.3.2 Likelihood maximization
Estimation of the PT mixed model can be performed using the function ptmixed()
available in the R package ptmixed (Signorelli et al. 2020). This function maximizes
the marginal likelihood of the model using the computational approach outlined below,
and it allows a certain degree of flexibility in the choice of the number of quadrature
points, starting points and maximum number of iterations, as well as of the convergence
criterion.
A critical point in the efficiency and success rate of the maximization is the choice
of good starting values. As initial values for β and σ2 we employ the maximum like-
lihood estimates of those parameters from a negative binomial GLMM or, when its
estimation fails, from a Poisson GLMM; for the dispersion parameter D we consider
either a method of moments estimate, or the ML estimator of D obtained by fitting a
negative binomial GLMM through the function nbmixed(), that estimates the simpler
NB GLMM. For the power parameter a, we use the method of moment estimator of a
for the density of the PT distribution.
Numeric maximization of the likelihood function in (2) is carried out using the Nelder-
Mead (NM, Nelder and Mead 1965) algorithm (as implemented in the function optim());
when the NM method fails, a second attempt is made using the Broyden-Fletcher-
Goldfarb-Shanno (BFGS) algorithm. Because NM may require to evaluate the like-
lihood function several thousands of times, ptmixed offers the possibility to either
update the position of the quadrature points at each iteration of the NM algorithm, or
after every k iterations. In practice, maximization of the likelihood when the variance
of the random intercept is very small may sometimes fail irrespective of the starting
values and algorithm used; for this reason, when the starting value for σ2 < ε we remove
the random intercept and fit a PT GLM (we set ε = 0.001 as default in ptmixed()).
2.4 Inference
We base the evaluation of the standard errors of the parameter estimates on the
asymptotic distribution of the ML estimator (El-Shaarawi et al., 2011), and use the
Wald and the likelihood ratio tests for hypotheses testing. If θˆ is the ML estimate
of θ = (β,D, a, σ2), then the asymptotic distribution of θˆ is multivariate normal with
mean θ and variance V = ˆV ar(θˆ) = I−1(θˆ), where I(θˆ) denotes the observed Fisher
information evaluated at θ = θˆ (McCulloch et al., 2008).
Hypotheses that involve linear combinations of regression coefficients can be expressed
as H0 ∶KTβ =KT b0 and tested with the Wald test statistic
w = (KT βˆ −KT b0)T (KTV ar(βˆ)K)−1 (KT βˆ −KT b0),
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whose asymptotic distribution when H0 is true is χ2d, with d = rank(K). Hypotheses
that can be expressed in the form H0 ∶ θ ∈ Θ0, where Θ0 is a subset of the parameter
space Θ, can be verified with the the likelihood ratio test (LRT) statistic t = 2 logL(θˆ)−
2 logL(θˆ0), where θˆ0 = argminθ∈Θ0L(θ). When the null hypothesis does not involve
testing values of θ on the boundary of Θ, the asymptotic distribution of t under H0
is χ2d, where d is the number of restrictions implied by H0. If, instead, the hypothesis
involves values on the boundary of the parameter space, the asymptotic distribution
of t is not χ2 in general; however, it is possible to show that in certain cases, such
as for example when H0 ∶ σ2 = 0, the asymptotic distribution of t is a mixture of χ2
distributions (Molenberghs and Verbeke, 2007).
2.5 The R package ptmixed
Table 1: Overview of the functions currently available in the R package ptmixed (Sig-
norelli et al. 2020, package version 0.5.2).
Function Description
make.spaghetti Creates a trajectory (“spaghetti”) plot to visualize the trajectories
of a longitudinal outcome of interest
nbglm Estimation of a negative binomial GLM
nbmixed Estimation of a negative binomial GLMM
pmf Computes and plots the empirical pmf of the response variable
ptglm Estimation of a Poisson-Tweedie GLM
ptmixed Estimation of a Poisson-Tweedie GLMM
ranef Computation of the random effects BLUP
for the negative binomial and Poisson-Tweedie GLMMs
summary.ptglm Computation of the standard errors and univariate Wald tests
for the negative binomial and Poisson-Tweedie GLMs
summary.ptglmm Computation of the standard errors and univariate Wald tests
for the negative binomial and Poisson-Tweedie GLMMs
wald.test Computation of the multivariate Wald test
We have implemented the computational approach for ML estimation outlined in Sec-
tion 2.3 in the R package ptmixed, which can be freely downloaded from CRAN (Signorelli
et al., 2020). The package comprises functions for the estimation of the Poisson-
Tweedie GLMM and of simpler models such as the Poisson-Tweedie GLM and the
negative binomial GLM and GLMM. Table 1 provides an overview of the functions
currently available in the package; these functions can be used for data visualization
(pmf and make.spaghetti); to fit the PT GLMM (ptmixed), NB GLMM (nbmixed),
PT GLM (ptglm) and NB GLM (nbglm); to summarize the results of each model fit
(summary.ptglm and summary.ptglmm); to perform hypothesis testing (wald.test);
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Table 2: RMSE of βˆ2 in simulation A. Values in each cell are estimated using 5000
random replicates.
n a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.043 0.043 0.042 0.041 0.024
n = 25 0.026 0.027 0.026 0.025 0.015
n = 50 0.018 0.019 0.018 0.018 0.010
n = 100 0.013 0.013 0.013 0.012 0.008
n = 150 0.010 0.011 0.010 0.010 0.006
and, for the GLMMs, to obtain the best linear unbiased predictor (BLUP) of the ran-
dom effects (ranef). Finally, a vignette that illustrates how to use these functions can
be found at https://cran.r-project.org/package=ptmixed
3 Simulations
In this section we evaluate the performance of ptmixed through several simulations.
We begin by evaluating the accuracy of our approach for ML estimation and hypothesis
testing across a range of different distributional shapes (from zero-inflated to heavy-
tailed) and sample sizes (Section 3.1). In Section 3.2 we show the added value of
approximating the likelihood function with the AGHQ method by comparing it to the
LA. Finally, in Section 3.3 we compare the performance of our method to that of several
state of the art approaches for the analysis of RNA-seq data. R scripts to reproduce
the results presented here are available at https://github.com/m-signo/ptmixed.
3.1 Accuracy of ML estimates and hypothesis testing
To assess the accuracy of the ML estimates and of the Wald and likelihood ratio tests
computed following the procedures outlined in Section 2.4, we simulated data from the
PT mixed model in (1) considering five different values of the power parameter a, so as
to cover a wide range of distributional shapes: zero-inflated (a = −5,−1), NB (a = 0),
heavy-tailed (a = 0.5) and Poisson (a = 1). We fixed the dispersion parameter D = 3
(except for the case a = 1, where D = 1) and the number of repeated measurements
per subject mi = 5 ∀i ∈ {1, ..., n}, and progressively increased the number of subjects
n ∈ {10,25,50,100,150}. We splitted individuals into two groups, denoted by di ∈ {0,1},
of equal size. We let the mean µij depend on a subject-specific random intercept vi,
on group di and time ti in such a way that log(µij) = β0 + vi + β1di + β2tij, with
vi ∼ N(0, σ2 = 0.5).
In simulation A we let β = (2.5,0.3,0) and test whether the time effect is null, i.e.
H0 ∶ β2 = 0. Table 2 reports the root mean square error (RMSE) of βˆ2 for different
values of a and n. We can observe that the magnitude of the RMSE is comparable
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Table 3: False positive rates of the Wald and likelihood ratio tests for different values
of a and n in simulation A (H0 ∶ β2 = 0, α = 0.05). Values in each cell are estimated
using 5000 random replicates.
Wald test
a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.058 0.053 0.061 0.060 0.036
n = 25 0.045 0.053 0.048 0.052 0.039
n = 50 0.048 0.051 0.057 0.053 0.033
n = 100 0.051 0.053 0.051 0.054 0.042
n = 150 0.050 0.050 0.048 0.047 0.050
Likelihood ratio test
a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.050 0.048 0.053 0.053 0.023
n = 25 0.043 0.051 0.047 0.050 0.026
n = 50 0.046 0.051 0.056 0.053 0.027
n = 100 0.051 0.053 0.052 0.059 0.040
n = 150 0.049 0.053 0.051 0.054 0.046
Table 4: RMSE of βˆ1 in simulation B. Values in each cell are estimated using 5000
random replicates.
n a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.456 0.474 0.459 0.473 0.448
n = 25 0.203 0.206 0.199 0.197 0.141
n = 50 0.207 0.210 0.208 0.204 0.203
n = 100 0.147 0.146 0.146 0.145 0.143
n = 150 0.119 0.122 0.119 0.122 0.117
across different values of a, and that it decreases linearly with
√
n as expected. Table
3 compares the false positive rate (FPR) at α = 0.05 between the Wald test and LRT
for each of the distributions considered and increasing sample size; we observe that the
two tests exhibit similar performance, producing an FPR close to the nominal type I
error (α = 0.05) already with small sample sizes.
In simulation B, instead, we let β = (2.5,0,0.2) and test whether the group coefficient
is null, i.e. H0 ∶ β1 = 0. Also in this case we see that the RMSE of the parameter of
interest (here βˆ1) is of comparable magnitude across different values of a, and that as
expected it decreases linearly with
√
n (Table 4). Assessment of the FPR at α = 0.05
(Table 5) points out that for very small sample sizes (namely n = 10) both the Wald
test and LRT are anti-conservative. For larger sample sizes, both methods achieve
FPRs much closer to α = 0.05.
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Table 5: False positive rates of the Wald and likelihood ratio tests for different values
of a and n in simulation B (H0 ∶ β1 = 0, α = 0.05). Values in each cell are estimated
using 5000 random replicates.
Wald test
a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.110 0.129 0.117 0.125 0.116
n = 25 0.064 0.063 0.057 0.059 0.048
n = 50 0.056 0.058 0.060 0.056 0.062
n = 100 0.060 0.056 0.055 0.055 0.058
n = 150 0.049 0.056 0.050 0.062 0.051
Likelihood ratio test
a = -5 a = -1 a = 0 a = 0.5 a = 1
n = 10 0.080 0.093 0.085 0.092 0.057
n = 25 0.058 0.060 0.054 0.056 0.031
n = 50 0.051 0.054 0.055 0.051 0.042
n = 100 0.056 0.053 0.052 0.054 0.043
n = 150 0.048 0.054 0.049 0.061 0.039
3.2 Comparison between the AGHQ and Laplace approxima-
tions of the likelihood
To quantify the improvement associated to the use of the AHGQ in the approximation
of the likelihood of our model, we illustrate a comparison of its performance to that of
the LA, focusing on the case with a = −1 and n = 100 considered in simulation B (for
the description of the settings of this simulation, see Section 3.1). Table 6 compares the
mean of the ML estimates obtained when using the LA or an AGHQ with 5 quadrature
points. The results show that even for n = 100 the LA can yield rather biased parameter
estimates, in particular for D, a and σ2. Use of the AGHQ makes it possible to obtain
more accurate parameter estimates for all parameters.
Table 6: Evaluation of the bias of the ML estimates obtained using the LA and the
AGHQ. Values in each cell are estimated using 5000 random replicates.
true value Laplace AGHQ
β0 2.500 2.483 2.493
β1 0.000 0.003 0.001
β2 0.200 0.202 0.199
D 3.000 2.612 3.108
a -1.000 -2.520 -0.653
σ2 0.500 0.435 0.471
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Importantly, use of the AGHQ produced considerably higher convergence rates (87.5%
versus the 65.2% of the LA) using the default starting values computed by ptmixed
(thus reducing the risk that one may need to try different starting points to ensure
convergence). Furthermore, the AGHQ reduced the proportion of false positives (5.6%
versus 7% for the LA, α = 0.05) enabling a better type I error control. All these
performance improvements are due to the fact that the use of more quadrature points
allowed a better approximation of the likelihood function, and they required on average
a 12% increase in computing time with respect to the LA (Table 7).
Table 7: Convergence rate, estimated FPR and mean computing time using the LA
and the AGHQ. Values in each cell are estimated using 5000 random replicates.
Laplace AGHQ
Convergence 65.2% 87.5%
False positive rate (α = 0.05) 0.070 0.056
Mean computing time (minutes) 10.3 11.5
3.3 Comparison with alternative modelling approaches
In this Section we describe the results of two simulation studies (C and D) designed
to compare ptmixed to several state of the art approaches that are typically employed
in the analysis of longitudinal RNA-seq data. Contrary to Section 3.1, where we
assessed the performance of our method in parameter estimation and testing for a fixed
θ = (β,D, a, σ2), here we evaluate the overall performance of each method on simulated
datasets comprising G = 500 genes each (i.e., each gene has a different θg); the reason
for this is that some of the methods included in the comparison (DESeq2, edgeR and
limma-voom) carry out parameter estimation by borrowing information across different
genes, and therefore they require information from all genes to estimate and test the
parameters associated to each individual gene.
We simulate datasets comprising gene expression values of G = 500 genes for a sample
of n subjects who are splitted into two groups of equal size. We assume that mi = 5
repeated measurements are available for each subject. The data are generated from
model (1) assuming that
log(µgij) = βg0 + βg1di + βg2tij + oij + vgi,
where di ∈ {0,1} is the group indicator, tij ∈ {0,1, ...,4} represents time, oij ∼ N(0,0.52)
is an offset term whose purpose is to mimic the presence of sample-specific normaliza-
tion weights, vgi ∼ N(0, σ2g) with σ2g ∼ U(0.2,0.8) is a random intercept, and the dis-
persion parameter D follows a translated gamma distribution, D − 1 ∼ Γ(α = 2, β = 1).
Consistently with the results of Esnaola et al. (2013), who showed that the hypothe-
sis that the distribution of RNA-seq counts is NB cannot be rejected for most genes,
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Table 8: List of methods compared in simulations C and D.
Method Model type Assumption about Reference
acronym repeated measurements
DESeq2 NB GLM Independence Love et al. (2014)
DESeq2+FE NB GLM Fixed effects Love et al. (2014)
edgeR NB GLM Independence Robinson et al. (2010)
edgeR+FE NB GLM Fixed effects Robinson et al. (2010)
limma-voom Gaussian LM Independence Law et al. (2014)
limma-voom+FE Gaussian LM Fixed effects Law et al. (2014)
MaSigPro NB GLM Independence Nueda et al. (2014)
ptmixed PT GLMM Random effects Signorelli et al. (2020)
tweeDEseq PT GLM Independence Esnaola et al. (2013)
ShrinkBayes ZINB GLMM Random effects van de Wiel et al. (2014)
but that at the same time the distribution is not NB for a relevant proportion of
genes, we let the distribution of Ygij to be NB (ag = 0) for 300 genes, zero-inflated
(ag ∼ U(−10,−1)) for 100 genes and heavy-tailed (ag ∼ U(0.3,0.7)) for the remaining
100 genes.
We have included in this comparison approaches that (i) treat repeated measurements
from the same individual as independent, (ii) include the subject identifiers as fixed
effects into the model, and (iii) use random effects to model the correlation induced
by the repeated measurements design. An overview of the methods considered is given
in Table 8, where we summarize the type of model used and the way in which they
handle the repeated measurements design. All methods were fitted specifying as fixed
effects the main effect of group and time, with the exception of MaSigPro where also
an interaction term was included (in the R package MaSigPro the interaction term is
automatically included and cannot be suppressed). As concerns hypothesis testing, for
ptmixed we assessed the performance of both the Wald test and the LRT introduced
in Section 2.4.
In simulation C we compare the performance of each method in testing if a gene is up-
or down-regulated over time, i.e., βg2 = 0. We let βg0 ∼ N(3,0.5), βg1 ∼ N(0,0.3), and
we assume that 400 genes are not dysregulated over time (i.e., βg2 = 0), 50 genes are up-
regulated with βg2 ∼ U(0.1,0.5) and 50 genes downregulated with βg2 ∼ U(−0.5,−0.1).
In simulation D, instead, we check the performance of each method in testing if a
gene is differentially expressed (DE) between the two groups, i.e., βg1 = 0. We let
βg0 ∼ N(3,0.5), βg2 ∼ U(−0.1,0.1), and we assume that 400 genes are not DE (i.e.,
βg1 = 0), 50 genes are up-regulated with βg1 ∼ U(0.5,1) and 50 genes downregulated
with βg1 ∼ U(−1,−0.5).
First, we assess the precision of the parameter estimates obtained by the different
methods by comparing their RMSEs. We report the RMSE for all methods with
the exception of MaSigPro, for which the computation was not possible because this
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Table 9: RMSE of βˆ2 in simulation C.
Method n = 10 n = 20 n = 40
DESeq2 0.117 0.106 0.106
DESeq2+FE 0.124 0.114 0.112
edgeR 0.101 0.082 0.073
edgeR+FE 0.106 0.088 0.078
limma-voom 0.126 0.106 0.093
limma-voom+FE 0.110 0.093 0.082
ptmixed 0.120 0.051 0.039
ShrinkBayes 0.062 0.040 0.026
tweeDEseq 0.066 0.054 0.049
Table 10: RMSE of βˆ1 in simulation D.
Method n = 10 n = 20 n = 40
DESeq2 0.910 0.743 0.648
DESeq2+FE 4.406 4.419 4.424
edgeR 0.756 0.549 0.408
edgeR+FE 4.224 4.225 4.230
limma-voom 0.789 0.570 0.428
limma-voom+FE 23.076 23.091 23.077
ptmixed 0.066 0.049 0.035
ShrinkBayes 0.347 0.247 0.180
tweeDEseq 0.412 0.290 0.210
method reports parameter estimates only for the significant genes, and not for all
genes. Then, we evaluate the extent to which each method controls the type I error
by computing the False Positive Rate (FPR), which is the proportion of truly non-DE
genes that are declared as DE by the test at a fixed significance level α. Furthermore,
for the methods whose FPR appears to be under control we compare the True Positive
Rate (TPR), which is the proportion of truly DE genes that are correctly declared as
DE by the test at level α. Finally, we also present a comparison of the computing
times of each method. The results of all methods were corrected for multiple testing.
We employed the Benjamini-Hochberg (Benjamini and Hochberg, 1995) correction for
all methods list in Table 8, with the exception of ShrinkBayes, for which we employed
the Bayesian FDR suggested in van de Wiel et al. (2014). Results for each simulation
and sample size are based on 50 random replications (i.e., 50 datasets comprising 500
genes each).
Table 9 compares RMSE(βˆg2) in simulation C, where interest lies in the estimation
and testing of the time effect βg2, which is a within-subjects effect. In this simulation,
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Table 11: False Positive Rate in simulation C (H0 ∶ βg2 = 0, α = 0.05).
Method n = 10 n = 20 n = 40
DESeq2 0.001 0.004 0.048
DESeq2+FE 0.052 0.179 0.471
edgeR 0.000 0.000 0.000
edgeR+FE 0.005 0.005 0.005
limma-voom 0.000 0.000 0.000
limma-voom+FE 0.008 0.009 0.011
MaSigPro 0.000 0.000 0.000
ptmixed, LRT 0.023 0.030 0.044
ptmixed, Wald test 0.029 0.033 0.040
ShrinkBayes 0.032 0.031 0.025
tweeDEseq 0.005 0.005 0.004
the method with the lowest RMSEs is ShrinkBayes, closely followed by tweeDEseq
when n = 10 and n = 20, and by ptmixed when n = 20 and n = 40. The remaining
six methods are associated to larger RMSEs across all considered sample sizes. Table
10 compares RMSE(βˆg1) in simulation D, where interest lies in the estimation and
testing of the group effect βg1, which is a between-subjects effect. Here, ptmixed is
by far the method with the lowest RMSEs. The RMSEs of ShrinkBayes, tweeDEseq,
edgeR, limma and DEseq2 are between 5 and 20 times higher than those of ptmixed,
whereas the three approaches that use subject-specific fixed effects have extremely
high RMSEs that do not even decrease with n. This last result shows that attempts to
model longitudinal data using fixed effects can yield extremely inaccurate parameter
estimates of between-subjects effects.
Table 11 reports the estimated FPRs in simulation C. Overall, we can observe that in
this case almost all methods control the type I error, achieving an FPR < 5% for all
sample sizes. The only exception to this is DESeq2+FE. It can also be noted that the
FPRs of the two mixed-effects modelling approaches, ptmixed (both with the Wald
test and the LRT) and ShrinkBayes, are much closer to the prespecified α than those
of all other methods, which appear to be more conservative.
The estimated TPRs for the methods that control the type I error in simulation C
are shown in Table 12. In general, all methods achieve comparable TPRs, with the
exception of MaSigPro whose TPR is almost 0 for all n. The methods with the highest
TPR when n = 10 are the three fixed-effects approaches, whereas for n = 20 and
n = 40 edgeR+FE and limma-voom+FE are the most powerful, followed by ptmixed,
ShrinkBayes and tweeDEseq.
The estimated FPRs in simulation D are presented in Table 13. In this case, ptmixed
and MaSigPro control the type I error across all sample sizes, and ShrinkBayes does so
for n = 20 and n = 40. All other methods fail to control the type I error, producing much
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Table 12: True Positive Rate in simulation C (H0 ∶ βg2 = 0, α = 0.05) for the methods
that control the type I error (FPR ≤ α in Table 11). Asterisks (*) denote methods that
did not control the type I error (see Table 11).
Method n = 10 n = 20 n = 40
DESeq2 0.693 0.840 0.926
DESeq2+FE 0.884 * *
edgeR 0.634 0.815 0.937
edgeR+FE 0.847 0.947 0.985
limma-voom 0.622 0.807 0.927
limma-voom+FE 0.853 0.947 0.985
MaSigPro 0.025 0.009 0.002
ptmixed, LRT 0.750 0.893 0.968
ptmixed, Wald test 0.769 0.895 0.968
ShrinkBayes 0.663 0.876 0.961
tweeDEseq 0.736 0.860 0.951
Table 13: False Positive Rate in simulation D (H0 ∶ βg1 = 0, α = 0.05).
Method n = 10 n = 20 n = 40
DESeq2 0.286 0.289 0.323
DESeq2+FE 0.977 0.978 0.978
edgeR 0.234 0.234 0.238
edgeR+FE 0.977 0.979 0.977
limma-voom 0.194 0.184 0.190
limma-voom+FE 1.000 1.000 1.000
MaSigPro 0.000 0.000 0.000
ptmixed, LRT 0.003 0.005 0.012
ptmixed, Wald test 0.031 0.012 0.012
ShrinkBayes 0.120 0.035 0.022
tweeDEseq 0.342 0.316 0.307
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Table 14: True Positive Rate in simulation D (H0 ∶ βg1 = 0, α = 0.05) for the methods
that control the type I error (FPR ≤ α in Table 13). Asterisks (*) denote methods that
did not control the type I error (see Table 13).
Method n = 10 n = 20 n = 40
DESeq2 * * *
DESeq2+FE * * *
edgeR * * *
edgeR+FE * * *
limma-voom * * *
limma-voom+FE * * *
MaSigPro 0.001 0.000 0.000
ptmixed, LRT 0.040 0.228 0.607
ptmixed, Wald test 0.206 0.336 0.630
ShrinkBayes * 0.363 0.646
tweeDEseq * * *
higher FPRs: the approaches that assume independence (DESeq2, edgeR, limma-voom
and tweeDEseq) yield FPRs that range from 0.184 to 0.342, whereas the approaches
that employ fixed effects (DESeq2+FE, edgeR+FE and limma-voom+FE) have FPRs
close to 1.
The estimated TPRs for the methods that control the type I error in simulation D are
shown in Table 14. Once again, MaSigPro has TPRs close to 0, giving an indication
that the method has little power to reject H0 both in simulation C and simulation
D. As concerns ptmixed, the Wald test appears to be a bit more powerful than the
LRT, especially when n = 10 and n = 20. Finally, in the two cases in which it controls
the type I error (n = 20 and n = 40), ShrinkBayes achieves a TPR similar to that of
ptmixed’s Wald test.
In Tables 1 and 2 of Supplementary File 1 we report the computing time of each method
in simulations C and D. Overall, estimation of the GLMM approaches, ptmixed and
ShrinkBayes, was considerably slower than that of the other approaches that fit simpler
GLMs. For most methods, computing time increased linearly with n; this did not hold
for the fixed-effects approaches, where computing time increased more than linearly
with n, and for ShrinkBayes, which took more time to convergence when n = 10 than
when n = 20 or n = 40.
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4 Characterizing the dynamic evolution of Duchenne
Muscular Dystrophy in mouse
In this section we illustrate how the ptmixed can be employed to analyse longitudi-
nal RNA-seq data. We consider a longitudinal RNA-seq experiment performed at the
LUMC (Leiden, NL) whose aim was to characterize the dynamic evolution of gene
expression in mdx mice. The mdx mouse is the most used mouse model for DMD, an
X-linked recessive genetic disease caused by protein truncating mutations in the DMD
gene that encodes dystrophin. The progression of DMD is characterised by a process of
muscle degeneration and regeneration whose consequences are muscle instability and
the replacement of muscular tissue with fibrotic and fatty tissues. Eventually, this
process leads to loss of muscle function, loss of ambulation and premature death. To
date no effective treatment for DMD has been found; one of the reason for drug failure
during clinical trials is the use functional tests with high inter- and intra-individual
variability, resulting in underpowered studies. The possibility to quantify disease pro-
gression non-invasively with objective biomarkers is highly needed. In this experiment,
repeated blood measurements were taken in order to obtain estimates of the evolution
of blood-based gene expression over time.
The experiment involved five different groups of mice, but for simplicity of illustration
here we focus on the comparison of the two most interesting groups: wild-type (wt),
comprising 5 healthy mice, and mdx, comprising 3 dystrophic mice that shared the
same genetic background of wt mice but carried a nonsense mutation in exon 23 that
led to lack of dystrophin. Mice were kept under observation for 30 weeks, during
which blood samples were collected from each mouse every 6 weeks starting from 6
weeks of age. Transcriptomic expression in these samples was quantified using RNA-
sequencing (GEO accession number GSE132741). We focus our attention on those
genes that belong to 5 pathways, listed in Table 15, that are relevant in the DMD
pathophysiology. We filter out lowly expressed genes by excluding genes that have less
than 1 count per million in more than half of the samples; after filtering, 379 genes are
retained in the analysis.
Table 15: List of pathways considered in our analysis. The pathways were downloaded
form WikiPathways (Slenter et al., 2017).
Pathway Description Number of genes
WP113 TGFβ signaling sathway 48
WP246 TNFα NF-kB signaling pathway 175
WP387 IL-6 signaling pathway 29
WP3675 Factors and pathways affecting insulin-like 96
growth factor (IGF1)-Akt signaling
WP85 Focal adhesion 168
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We let the expression value for gene g from mouse i at the j-th time point follow a PT
GLMM where Ygij ∣ vgi ∼ PT(µgij, Dg, ag) and
log(µgij) = βg0 + βg1di + βg2tij + βg3ditij + oij + vgi, (5)
where di is a dummy variable which is 0 for wt and 1 for mdx mice, tij ∈ {0,1,2,3,4}
denotes time (0 = week 6, 4 = week 30) and oij is an offset term equal to the logarithm
of the effective library sizes computed using the TMM normalization method (Robinson
and Oshlack, 2010).
We estimated model 5 using an AGHQ with 10 quadrature points and considered up to
two different starting values (ptmixed default values and, when necessary, ML estimates
of the negative binomial GLMM) for the optimization. ML estimation was successful
for 315 genes; for the remaining 64 genes, for which estimation of model 5 failed, we
attempted to estimate the simpler NB mixed model by fixing ag = 0; estimation of such
model was successful for 63 of those genes. We do not consider further the remaining
gene, for which also estimation of the NB GLMM failed.
Figure 1 shows the distribution of the ML estimates of the power parameter, aˆg, for
the 315 genes for which estimation of the PT GLMM was successful. For 74 genes
aˆg < −1, for 62 genes aˆg ∈ [−1,0), for 106 genes aˆg ∈ [0,0.5), and for the remaining 72
genes aˆg ∈ [0.5,1). The spread of aˆg over a range of values far from 0 is an indication of
the fact that for several genes the NB distribution (that is, a PT with a = 0) does not
provide the best fit to the data, in line with the observations made by Esnaola et al.
(2013) about the distribution of cross-sectional RNA-seq data.
With the aim of identifying genes whose progression is different between mdx and wt
mice, we tested the null hypothesis H01 ∶ βg1 = βg3 = 0 of no difference in the average
expression level of gene g between cases and controls at any time point. p-values were
adjusted for multiple testing using the Benjamini-Hockberg method (Benjamini and
Hochberg, 1995). Detailed results of the test are provided in Supplementary File 2.
In short, we found evidence of differential expression (FDR-corrected p-value < 0.05)
for 120 genes; for these genes, we furthermore tested whether there was sufficient
evidence that the intercept or the slope are different between groups, H02 ∶ βg1 = 0
and H03 ∶ βg3 = 0 respectively. These tests allowed to further identify 38 genes with a
significant intercept (difference between wt and mdx at week 6) and 38 genes where
the progression (slope) is different between groups.
In Figure 2 we show the trajectories of four of the significant genes, Igfbp4, Jak1, Stat1
and Tgif1. Igfbp4 is one of the insulin-like growth factor binding proteins, it binds to
both IGF-1 and IGF-2 affecting the half-life of IGFs in circulation and their interaction
with cell receptors. IGF-1 has been linked to muscle regeneration and multiple papers
show a beneficial effect of IGF-1 in DMD (Forcina et al., 2019). IGF binding proteins
such as IGFBP3 and IGFBP5 have also been described to be reduced in DMD patients
serum compared to healthy controls (Hathout et al., 2019). In this work we observe a
significant elevation of Igfbp4 in mdx mice, which is particularly apparent at weeks 6
and 12 when intensive muscle degeneration and regeneration is ongoing. Jak1 and Stat1
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Figure 1: Histograms showing the distribution of the ML estimates of the power pa-
rameter. The left histogram shows the distribution of the ML estimates over the full
range of aˆg, whereas the right histogram zooms on the interval [−5,1], where most of
the distribution is concentrated.
are part of the JAK-STAT pathway; inspection of the trajectory plots in Figure 2 shows
that the two genes have a similar pattern of expression, with an elevation in mdx mice
at week 6 followed by a steep decrease at the later time points. It has been described
how the JAK-STAT pathway contributes to muscle repair promoting regeneration in
DMD (Moresi et al., 2019). The observed behaviour of Jak1 and Stat1 in mdx mice
is particularly interesting for two reasons: the intensive muscle regeneration ongoing
at 6 weeks of age in mdx mice, and the previous finding that Stat1 is activated in
mdx mice diaphragm at 6 weeks of age compared to healthy mice (Dogra et al., 2008).
Finally, for Tgif1 we can observe a downregulation in mdx mice at 6 and 12 weeks;
later on, the expression of the gene in mdx mice increases towards the levels observed
in wt mice. Tgif1 is part of the TGFβ pathway, a well known pathway in the DMD
pathophysiology with genetic modifiers mapping to this pathway (Flanigan et al., 2013)
and a number of reports involving TGFβ in DMD (Ceco and McNally, 2013).
In Figure 3 we compare the p-values for H01 ∶ βg1 = βg3 = 0 obtained from the PT mixed
model with those that would have been obtained if we had used a NB mixed model,
focusing on the 311 genes for which both models could be fitted. It can be observed
that while for several genes the p-values are quite similar, there are also numerous
instances of genes for which the choice between NB and PT matters, as it may entail
a different conclusion on the significance of the null hypothesis. In particular, p-values
obtained from the PT mixed model are smaller than those from the NB mixed model in
178 cases, and larger 133 times; after application of the Benjamini-Hochberg multiple
testing correction, 44 genes are found as significant (α = 0.05) with both the NB and
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Figure 2: Plots comparing the trajectories of selected genes in mdx (blue solid line)
and wt (red dashed line) mice.
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Figure 3: Scatter plot comparing the p-values for the hypothesis H01 ∶ βg1 = βg3 = 0
computed using the NB (x axis) and PT (y axis) mixed models.
the PT mixed model; furthermore, 12 genes are identified as significant just by the NB
mixed model, whereas 53 genes are found as significant only by the PT mixed model.
Overall, these results suggest that while there appears to be a good level of agreement
between the two models, identifying for each gene the most suitable distributional
shape within the PT family of distributions, rather than arbitrarily fixing ag = 0 and
choosing the NB distribution, can have important consequences on the identification
of differentially expressed genes and on downstream analyses.
5 Discussion
High-throughput RNA-sequencing technologies have become the standard method to
measure gene expression, progressively replacing microarrays. RNA-seq generates
count data that exhibit special features such as overdispersion, zero-inflation and heavy
tails. The analysis of RNA-seq data arising from longitudinal experiments should be
able to deal with such features and, at the same time, to account for the correla-
tion arising from the availability of repeated measurements from the same individual.
However, often such data are analysed with methods that either do not account for
overdispersion, zero-inflation and heavy tails (Esnaola et al., 2013), or fail to model
the dependence between repeated measurements (Cui et al., 2016).
In this article we have introduced ptmixed, a GLMM based on the PT distribution
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that can be employed to analyse of longitudinal sequencing data. On the one hand,
the reliance of ptmixed on the PT distribution allows to flexibly model the typical
distributional shapes of RNA-seq counts and, at the same time, to perform automatic
model selection thanks to the PT power parameter, which allows to distinguish be-
tween several overdispersed distributions that can be obtained as special cases of the
PT (Esnaola et al., 2013). On the other hand, ptmixed properly models the corre-
lation between repeated measurements obtained from the same subject through the
specification of subject-specific random effects. The applicability of ptmixed extends
beyond RNA-seq data, embracing all scenarios where non-independent measurements
of a discrete, overdispersed response variable are available; such settings can arise, for
example, in ecology (Bolker et al., 2009) and in clinical trials (Albert, 1999).
Our proposal represents the first theoretical development and software implementation
of a mixed model based on the PT distribution. An important contribution of our work
is to have shown that an accurate evaluation of the integrals in (2) makes it possible to
model longitudinal overdispersed counts using a GLMM that is more flexible than the
commonly used Poisson and NB GLMMs. In our experience, we have observed that
the rate of success for the estimation of the PT mixed model can be affected by the
sample size and on whether the values of a and σ2 lie on the boundary of the parameter
space; in particular, convergence appears to be easier with larger n, and to be more
difficult to achieve when the true a is very close to 1 or σ2 approaches 0.
The simulations presented in Sections 3.1 and 3.2 show that ptmixed allows to ac-
curately perform parameter estimation and hypothesis testing, and demonstrate the
advantage connected to the use of the AGHQ instead of the LA. Furthermore, in Section
3.3 we presented a comparison between ptmixed and alternative modelling approaches
through two genomewide simulations. Those simulations showed that analysing longi-
tudinal sequencing data with methods that do not properly model the repeated mea-
surements design (assuming independence or introducing subject-specific fixed effects)
yield inaccurate parameter estimates (Tables 9 and 10) and fail to control the type I
error in tests on between-subjects effects (Table 13). On the other hand, they showed
that use of GLMM approaches such as ptmixed and ShrinkBayes make it possible to
accurately estimate and test both within- and between-subject effects.
The results of Section 3.3 further allowed to compare ShrinkBayes and ptmixed. As
concerns parameter estimation, the RMSEs of ShrinkBayes were found to be 1.5 / 2
times smaller than those of ptmixed for within-subject effects (Table 9), but 5 times
larger than those of ptmixed for between-subjects effects (Table 10). Both methods
successfully controlled the FDR at α = 0.05 in simulation C (Table 11), but ShrinkBayes
did not control it when n = 10 in simulation D. Interestingly, ptmixed was somewhat
more powerful than ShrinkBayes in simulation C (Table 12), while the opposite was
found in simulation D (Table 14). Finally, the estimation of ptmixed was faster than
ShrinkBayes with small sample sizes, but slower with larger sample sizes. Overall,
the comparison pointed out that none of the two methods uniformly outperformed the
other, suggesting that both methods are valid modelling approaches with their own
advantages and weaknesses. Aside from those performance measures, there are a few
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additional features of ptmixed that make it more flexible than ShrinkBayes: as a matter
of fact, ptmixed is capable of modelling not only zero-inflation but also heavy-tails, it
allows to select a different distributional shape for each gene rather than fitting the
same distribution to all genes, and it allows to easily test not only simple univariate
hypotheses involving a single parameter, but also more general multivariate hypotheses
involving linear combinations of parameters and / or the joint significance of two or
more parameters.
In Section 4 we illustrated an application of ptmixed to data from a longitudinal RNA-
seq experiment involving WT and mdx mice. Through this application we showed
not only that ptmixed is capable to identify as differentially expressed many genes
known to play a major role in the evolution of Duchenne Muscular Dystrophy, but also
that using the more general PT GLMM instead of the simpler NB GLMM can yield
substantially different conclusions on which genes are differentially expressed. This
result points out the importance of properly modelling of zero-inflation and heavy-tails
not just from a theoretical point of view but also from an applied perspective, since
doing so can substantially change the conclusions of real data analyses.
Supplementary materials
Supplementary materials for this paper are available from http://www.statmod.org/
smij/archive.html.
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